Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2005
03/31/2005US20050069878 Proteins associated with cell growth, differentiation, and death
03/31/2005US20050069877 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
03/31/2005US20050069876 Polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune, inflammatory, cardiovascular, neurological and developmental disorders.
03/31/2005US20050069866 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
03/31/2005US20050069865 Synthetic hcv envelope proteins and their use for vaccination
03/31/2005US20050069572 Multi-layered polymerizing hydrogels for tissue regeneration
03/31/2005US20050069570 Method of cell taking on surface of article with three-dimensional structure
03/31/2005US20050069559 Lawsonia intracellularis vaccine
03/31/2005US20050069546 Educated NKT cells and their uses in the treatment of immune-related disorders
03/31/2005US20050069535 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides
03/31/2005US20050069534 Method of isolation and purification of trypsin from pronase protease and use thereof
03/31/2005US20050069529 Methods of making pancreatic islet cells
03/31/2005US20050069528 Mammalian endothelial cell model systems
03/31/2005US20050069527 Cell-based therapies for ischemia
03/31/2005US20050069525 Nerve repair unit and method of producing it
03/31/2005US20050069524 Methods for insertion of nucleic acids into circular vectors
03/31/2005CA2540155A1 Excretable reporter systems
03/31/2005CA2540138A1 Recombinant antibody against human insulin-like growth factor
03/31/2005CA2539670A1 Nanoliter-scale synthesis of arrayed biomaterials and screening thereof
03/31/2005CA2539613A1 Compositions for use in coating of substrate for cell sheet preparation, substrates for cell sheet preparation, and method for manufacturing cell sheets
03/31/2005CA2539457A1 Nucleic acid and gene derived from novel hcv strain and replicon-replicating cell using said gene
03/31/2005CA2539325A1 Consensus/ancestral immunogens
03/31/2005CA2539322A1 Kid3 and kid3 antibodies that bind thereto
03/31/2005CA2539274A1 Methods and compositions for the cryopreservation of organs
03/31/2005CA2539172A1 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine
03/31/2005CA2539065A1 Coumpounds for neutralising the effects of secreted pla2 iia
03/31/2005CA2539002A1 Method for isolating hepatocytes
03/31/2005CA2537462A1 Cell culture media comprising fructose as the primary energy source
03/31/2005CA2536972A1 Method for production of neurons from cells of a cell line
03/31/2005CA2526862A1 Methods of diagnosing, prognosing and treating breast cancer
03/30/2005EP1519192A2 HIV Protease inhibitor conjugates and antibodies useful in ummunoassay
03/30/2005EP1518933A1 Vectors and methods for gene transfer to cells
03/30/2005EP1518926A1 HUMAN IgM ANTIBODY LYSING ACTIVATED LYMPHOCYTES UNDER MEDIATION BY HOMOLOGOUS COMPLEMENT
03/30/2005EP1518864A2 Antibody against rhesus D
03/30/2005EP1517998A2 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
03/30/2005EP1517992A2 Retrons for gene targeting
03/30/2005EP1517988A2 Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure
03/30/2005EP1517987A2 Cotton rat lung cells for virus culture
03/30/2005EP1517923A2 Compositions and methods for inhibiting microbial adhesion
03/30/2005EP1517917A2 Human erg2 potassium channel
03/30/2005EP1517913A2 A mycobacterium tuberculosis coding sequence for exression of heterologous proteins
03/30/2005EP1517740A1 Tangential flow filtration devices and methods for leukocyte enrichment
03/30/2005EP1517715A2 Decellularized tissue
03/30/2005EP1517701A2 Lewis y epitope-containing mucin fusion polypeptide vaccines, compositions and methods of use thereof
03/30/2005EP1517700A2 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
03/30/2005EP1517695A2 Osteopontin, oligodendrocytes and myelination
03/30/2005EP1517606A2 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
03/30/2005EP1517604A2 No-apical meristem proteins, polynucleotides and methods of use for same
03/30/2005EP1429648A4 METHODS FOR SCREENING FOR SUBSTANCES WHICH INHIBIT FP PROSTANOID RECEPTOR INTERACTION WITH A COMPOUND HAVING PGF 2$g(a)alpha?ACTIVITY AND METHODS OF TREATING CANCER
03/30/2005EP1224298B1 Fibrinolytically active polypeptide
03/30/2005EP1203088B1 Conditionally controlled, attenuated hiv vaccine
03/30/2005EP1185867B1 Method for separating cells using immunorosettes
03/30/2005EP1124570A4 Novel neuropilin/growth factor binding and uses thereof
03/30/2005EP1080208B1 Dsrna-mediated regulation of gene expression in plants
03/30/2005EP1080187A4 Modification of cereal grain hardness via expression of puroindoline proteins
03/30/2005EP1056336B1 Selection of mature sperm by surface membrane determinants
03/30/2005EP1047777B1 Novel nucleic acid molecules correlated with the rhesus weak d phenotype
03/30/2005EP1025241B1 Multiply-substituted protease variants
03/30/2005EP1001978B1 Angiotensin derivatives
03/30/2005EP0791056B1 Lipid-cleavage enzyme complex
03/30/2005EP0585415B1 Dna encoding a human 5-ht 1e receptor and uses thereof
03/30/2005EP0542830B1 Assay methods and compositions for detecting and evaluating the intracellular transduction of an extracellular signal
03/30/2005CN1602360A Methods of increasing endogenous erythropoietin (EPO)
03/30/2005CN1602359A Methods of preparing a targeting vector and uses thereof
03/30/2005CN1602358A Recombinant fusion proteins and the trimers thereof
03/30/2005CN1602357A Novel phytases and method for producing these phytases
03/30/2005CN1602356A Transgenic organism expressing fungal MRP-like ABC transporters
03/30/2005CN1602354A Human coagulation factor VII polypeptides
03/30/2005CN1602351A Islet cells from human embryonic stem cells
03/30/2005CN1602350A Device for active phase cell or tissue sampling and uses thereof
03/30/2005CN1602317A Angiopoietin-2 specific binding agents
03/30/2005CN1602316A Flavivirus NS1 subunit vaccine
03/30/2005CN1602315A Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
03/30/2005CN1602204A Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies
03/30/2005CN1602201A Peptides and related compounds having thrombopoietic activity
03/30/2005CN1600851A Method for raising efficiency for producing transgenic animal
03/30/2005CN1195229C Prepn and application of human estrin receptor-resisting monoclonal antibody and human progestogen-resisting monoclonal antibody
03/30/2005CN1195063C Proteinase inhibitor fusion proteins
03/30/2005CN1195057C Method for separating viral particles
03/30/2005CN1195055C Method for establishing hematopoietic stem cells bank by extracting hematopoietic cells from placenta tissues
03/29/2005US6872874 Inbred maize line PH890
03/29/2005US6872873 Inbred maize line PH7BW
03/29/2005US6872870 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment
03/29/2005US6872814 Chlamydia antigens and corresponding DNA fragments and uses thereof
03/29/2005US6872811 HRPCa9 and HRPCa10 nucleic acids and polypeptides
03/29/2005US6872569 In vitro production of haploid germ cells
03/29/2005US6872567 Propagating and recovering preferential cells from culture; obtain cell sample, expose to antibody, separate cells bound to antibody, recover and propagate bound cells
03/29/2005US6872561 Forming viruses
03/29/2005US6872558 Heparanase-2 a member of the heparanase protein family
03/29/2005US6872556 Invention provides DNAs, vectors and host cells for the efficient production of various enzymes in the mevalonate pathway or for converting isopentyl pyrophosphate to farnesyl pyrophosphate synthase
03/29/2005US6872555 Nucleotide sequences for use in generating fructose polymers for food processing
03/29/2005US6872551 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
03/29/2005US6872549 From mammal cells transformed with cytomegalovirus vector using xanthine derivatives (caffeine and/or theobromine) and/or hexamethylene bisacetamide; serum-free
03/29/2005US6872548 Polypeptide for use in animal models associated with human therapeutics
03/29/2005US6872528 Cell culture; for use as tool in gene therapy and cel packaging
03/29/2005US6872525 Method for selectively separating live cells expressing a specific gene
03/29/2005US6872518 Therapeutic treatment of human tumors, cancers and infected cells; a viral vector containing a DNA insert as antitumor agents, anticarcinogenic agents, viricides, fungicides, bactericides
03/29/2005US6872395 Viruses comprising mutant ion channel protein
03/29/2005US6872393 Polyalkylene oxide-modified single chain polypeptides
03/29/2005US6872391 Nucleotide sequences coding polypeptide for use in the treatment of eating disorders